See also this year's filing and all EDGAR filings for this company.
PDF Report 0001420565_2021_Rein_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001420565, Rein Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,326,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 15,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 3,960,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 219,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,452,028 |
| 9 | ResearchAndDevelopmentExpense | 8,653,489 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 587,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,493 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,341,000 |
| 1 | Liabilities | 4,179,000 |
| 2 | Expenses | 16,105,517 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 12,162,000 |
| 5 | NetIncome | -15,518,517 |
| 6 | ComprehensiveNetIncome | -15,519,264 |
| 7 | BaseVar | 18,607,005 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.07 |
| 9 | EconomicCapitalRatio | 2.36 |